Received Mar 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z014409 | — |
no symptomatic AE/ No additional AE; PROQUAD that had an excursion on 20-JAN-2026. The caller reports that a dose was administered to patient on 26-FEB-2026.; This Spontaneous report was received from a nurse and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 26-Feb-2026, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live lyophilisate and solvent for solution for injection (PROQUAD) 1 dose (valid lot# Z014409; expiration date: 10-Mar-2027) (exact dose and route of administration were not reported) for prophylaxis. The vaccine was reconstituted using sterile diluent (lot# and expiration date were not reported). It was reported that the vaccine experienced temperature excursion on 20-Jan-2026 (Product storage error). It was confirmed that there was no symptomatic AE (No adverse event). Lot# (regarding sterile diluent) is being requested and will be submitted if received.
MERCK STERILE DILUENT